Nonpolymeric nanoassemblies for ocular administration of acyclovir: Pharmacokinetic evaluation in rabbits

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 1, 2012, Pages 39-45

  Stella, Barbara ^a   Arpicco, Silvia ^a   Rocco, Flavio ^a   Burgalassi, Susi ^b   Nicosia, Nadia ^b   Tampucci, Silvia ^b   Chetoni, Patrizia ^b   Cattel, Luigi ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Acyclovir; Nanoassemblies; Ocular pharmacokinetic; Rabbits; Squalene

Indexed keywords

4' TRISNORSQUALENOYLACYCLOVIR; ACICLOVIR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; AQUEOUS SOLUTION; ARTICLE; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG SYNTHESIS; LACRIMAL FLUID; LIPOPHILICITY; MALE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRECIPITATION; ZETA POTENTIAL;

ACYCLOVIR; ADMINISTRATION, OPHTHALMIC; ANIMALS; ANTIVIRAL AGENTS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; MALE; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PRODRUGS; RABBITS; SOLUBILITY; SQUALENE; TEARS;

EID: 83955162872     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.10.001     Document Type: Article

References (46)

1. D.M. Maurice, and S. Mishima Ocular pharmacokinetics M.C. Sears, Pharmacology of the Eye 1984 Springer-Verlag Berlin-Heidelberg, Germany 19 116
2. V.H.L. Lee Precorneal, corneal and postcorneal factors A.K. Mitra, Ophthalmic Drug Delivery Systems 1993 Marcel Dekker New York, USA 59 81
3. V.H. Lee, and J.R. Robinson Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits J. Pharm. Sci. 68 1979 673 684 (Pubitemid 9214368)
4. N.L. Burstein, and J.A. Anderson Corneal penetration and ocular bioavailability of drugs J. Ocul. Pharmacol. 1 1985 309 326 (Pubitemid 17187200)
5. R.D. Schoenwald Ocular drug delivery. Pharmacokinetic considerations Clin. Pharmacokinet. 18 1990 255 269 (Pubitemid 20134535)
6. A. Urtti, and L. Salminen Minimizing systemic absorption of topically administered ophthalmic drugs Surv. Ophthalmol. 37 1993 435 456 (Pubitemid 23144013)
7. Y.H. Lee, U.B. Kompella, and V.H. Lee Systemic absorption pathways of topically applied beta adrenergic antagonists in the pigmented rabbit Exp. Eye Res. 57 1993 341 349 (Pubitemid 23288813)
8. H. Sasaki, K. Yamamura, K. Nishida, J. Nakamura, and M. Ichikawa Delivery of drugs to the eye by topical application Prog. Retin. Eye Res. 15 1996 583 620 (Pubitemid 26329186)
9. V.J. Stella, W.N. Charman, and V.H. Naringrekar Prodrugs. Do they have advantages in clinical practice? Drugs 29 1985 455 473 (Pubitemid 15056470)
10. R. Gaudana, J. Jwala, S.H. Boddu, and A.K. Mitra Recent perspectives in ocular drug delivery Pharm. Res. 26 2009 1197 1216
11. R. Gaudana, H.K. Ananthula, A. Parenky, and A.K. Mitra Ocular drug delivery AAPS J. 12 2010 348 360
12. D.J. Coster, K.R. Wilhelmus, R. Michaud, and B.R. Jones A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis Br. J. Ophthalmol. 64 1980 763 765 (Pubitemid 11238339)
13. D.M. Richards, A.A. Carmine, R.N. Brogden, R.C. Heel, T.M. Speight, and G.S. Avery Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy Drugs 26 1983 378 438
14. J.J. Sanitato, P.A. Asbell, E.D. Varnell, G.E. Kissling, and H.E. Kaufman Acyclovir in the treatment of herpetic stromal disease Am. J. Ophthalmol. 98 1984 537 547 (Pubitemid 15206661)
15. J.J. O'Brien, and D.M. Campoli-Richards Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy Drugs 37 1989 233 309 (Pubitemid 19083613)
16. J. Colin, F. Malet, and C. Chastel Acyclovir in herpetic anterior uveitis Ann. Ophthalmol. 23 1991 28 30
17. G. Giammona, G. Puglisi, G. Cavallaro, A. Spadaro, and G. Pitarresi Chemical-stability and bioavailability of acyclovir coupled to alpha,beta-poly(N-2-hydroxyethyl)-Dl-aspartamide J. Control. Release 33 1995 261 271
18. I. Taskintuna, A.S. Banker, M. Flores-Aguilar, G. Bergeron-Lynn, K.A. Aldern, K.Y. Hostetler, and W.R. Freeman Evaluation of a novel lipid prodrug for intraocular drug delivery: effect of acyclovir diphosphate dimyristoylglycerol in a rabbit model with herpes simplex virus-1 retinitis Retina 17 1997 57 64 (Pubitemid 27091651)
19. B.S. Anand, J. Patel, and A.K. Mitra Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2 J. Pharmacol. Exp. Ther. 304 2003 781 791 (Pubitemid 36152357)
20. B.S. Anand, S. Katragadda, Y.E. Nashed, and A.K. Mitra Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium Curr. Eye Res. 29 2004 153 166 (Pubitemid 39556924)
21. R.S. Talluri, S.K. Samanta, R. Gaudana, and A.K. Mitra Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir Int. J. Pharm. 361 2008 118 124
22. C. Giannavola, C. Bucolo, A. Maltese, D. Paolino, M.A. Vandelli, G. Puglisi, V.H. Lee, and M. Fresta Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability Pharm. Res. 20 2003 584 590 (Pubitemid 36438901)
23. M. Fresta, A.M. Panico, C. Bucolo, C. Giannavola, and G. Puglisi Characterization and in vivo ocular absorption of liposome-encapsulated acyclovir J. Pharm. Pharmacol. 51 1999 565 576 (Pubitemid 29319782)
24. S.L. Law, K.J. Huang, and C.H. Chiang Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption J. Control. Release 63 2000 135 140 (Pubitemid 30046949)
25. P. Chetoni, S. Rossi, S. Burgalassi, D. Monti, S. Mariotti, and M.F. Saettone Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits J. Ocul. Pharmacol. Ther. 20 2004 169 177 (Pubitemid 38456590)
26. L. Cattel, M. Ceruti, G. Balliano, and F. Viola 2,3-Oxidosqualene cyclase and squalene epoxidase as target enzymes for the development of new sterol biosynthesis inhibitors W.D. Nes, E.J. Parish, J.M. Trzaskos, Regulation of Isopentenoid Metabolism 1992 American Chemical Society Washington, USA 174 191
27. P. Couvreur, B. Stella, L.H. Reddy, H. Hillaireau, C. Dubernet, D. Desmaele, S. Lepetre-Mouelhi, F. Rocco, N. Dereuddre-Bosquet, P. Clayette, V. Rosilio, V. Marsaud, J.M. Renoir, and L. Cattel Squalenoyl nanomedicines as potential therapeutics Nano Lett. 6 2006 2544 2548 (Pubitemid 46076946)
28. E.E. van Tamelen Bioorganic chemistry: sterols and acrylic terpene terminal expoxides Accounts Chem. Res. 1 1968 111 120
29. L. Pogliani, M. Milanesio, M. Ceruti, and D. Viterbo Conformational and dynamical study of squalene derivatives. III: Azasqualenes and solvated squalene Chem. Phys. Lipids 103 1999 81 93 (Pubitemid 29492863)
30. W.D.H. Gillan Tear biochemistry: a review S. Afr. Optom. 69 2010 100 106
31. R.J. Cenedella, and C.R. Fleschner Cholesterol biosynthesis by the cornea. Comparison of rates of sterol synthesis with accumulation during early development J. Lipid Res. 30 1989 1079 1084 (Pubitemid 19183960)
32. M. Ceruti, G. Balliano, F. Viola, G. Grosa, F. Rocco, and L. Cattel 2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase J. Med. Chem. 35 1992 3050 3058
33. M.G. Sarpietro, D. Micieli, F. Rocco, M. Ceruti, and F. Castelli Conjugation of squalene to acyclovir improves the affinity for biomembrane models Int. J. Pharm. 382 2009 73 79
34. H. Fessi, F. Puisieux, J.P. Devissaguet, N. Ammoury, and S. Benita Nanocapsule formation by interfacial polymer deposition following solvent displacement Int. J. Pharm. 55 1989 R1 R4
35. R. Cavalli, M.R. Gasco, P. Chetoni, S. Burgalassi, and M.F. Saettone Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin Int. J. Pharm. 238 2002 241 245 (Pubitemid 34457892)
36. N.A. Epshtein Validation of HPLC techniques for pharmaceutical analysis Pharm. Chem. J. 38 2004 212 228 (Pubitemid 39162893)
37. H. Matsumoto, C. Kaneko, K. Yamada, T. Takeuchi, T. Mori, and Y. Mizuno A convenient synthesis of 9-(2-hydroxyethoxymethyl)guanine (acyclovir) and related-compounds Chem. Pharm. Bull. 36 1988 1153 1157
38. S. Majumdar, T. Hingorani, R. Srirangam, R. Gadepalli, J.M. Rimoldi, and M.A. Repka Transcorneal permeation of l- and d-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement Pharm. Res. 26 2009 1261 1269
39. S. Katragadda, S. Gunda, S. Hariharan, and A.K. Mitra Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections Int. J. Pharm. 359 2008 15 24
40. E. Vega, F. Gamisans, M.L. Garcia, A. Chauvet, F. Lacoulonche, and M.A. Egea PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions J. Pharm. Sci. 97 2008 5306 5317
41. E.B. Souto, S. Doktorovova, E. Gonzalez-Mira, M.A. Egea, and M.L. Garcia Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs Curr. Eye Res. 35 2010 537 552
42. V.H. Lee, K.W. Morimoto, and R.E. Stratford Jr. Esterase distribution in the rabbit cornea and its implications in ocular drug bioavailability Biopharm. Drug Dispos. 3 1982 291 300 (Pubitemid 13217252)
43. M.G. Sarpietro, F. Rocco, D. Micieli, S. Ottimo, M. Ceruti, and F. Castelli Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface Int. J. Pharm. 395 2010 167 173
44. C. Huang, and S. Li Calorimetric and molecular mechanics studies of the thermotropic phase behavior of membrane phospholipids Biochim. Biophys. Acta 1422 1999 273 307 (Pubitemid 29512381)
45. L. Sau-Hung Spence, and J.R. Robinson The contribution of anionic polymer structural features to mucoadhesion J. Control. Release 5 1988 223 231 (Pubitemid 18038211)
46. G. Meseguer, R. Gurny, P. Buri, A. Rozier, and B. Plazonnet Gamma-scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine Int. J. Pharm. 95 1993 229 234 (Pubitemid 23203156)